LU82818A1 - Compositions pharmaceutiques pour nutrition parenterale - Google Patents

Compositions pharmaceutiques pour nutrition parenterale Download PDF

Info

Publication number
LU82818A1
LU82818A1 LU82818A LU82818A LU82818A1 LU 82818 A1 LU82818 A1 LU 82818A1 LU 82818 A LU82818 A LU 82818A LU 82818 A LU82818 A LU 82818A LU 82818 A1 LU82818 A1 LU 82818A1
Authority
LU
Luxembourg
Prior art keywords
carnitine
glucose
pharmaceutical compositions
acyl
compositions according
Prior art date
Application number
LU82818A
Other languages
English (en)
French (fr)
Inventor
C Cavazza
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of LU82818A1 publication Critical patent/LU82818A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU82818A 1979-10-05 1980-10-02 Compositions pharmaceutiques pour nutrition parenterale LU82818A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT5046779 1979-10-05
IT50467/79A IT1120033B (it) 1979-10-05 1979-10-05 Composizione farmaceutica comprendente-carnitina adatta per l'alimentazione parenterale

Publications (1)

Publication Number Publication Date
LU82818A1 true LU82818A1 (fr) 1981-02-02

Family

ID=11273028

Family Applications (1)

Application Number Title Priority Date Filing Date
LU82818A LU82818A1 (fr) 1979-10-05 1980-10-02 Compositions pharmaceutiques pour nutrition parenterale

Country Status (13)

Country Link
US (1) US4320145A (de)
JP (1) JPS5661310A (de)
AT (1) AT395111B (de)
BE (1) BE885527A (de)
CA (1) CA1154678A (de)
CH (1) CH641675A5 (de)
DE (1) DE3037479A1 (de)
FR (1) FR2468371A1 (de)
GB (1) GB2059262B (de)
IL (1) IL61190A (de)
IT (1) IT1120033B (de)
LU (1) LU82818A1 (de)
NL (1) NL8005450A (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3026368A1 (de) * 1980-07-11 1982-02-18 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Naehrloesung fuer die vollstaendige parenterale ernaehrung und fuer gesteigerte energieproduktion
IT1157238B (it) * 1982-10-29 1987-02-11 Sigma Tau Ind Farmaceuti Impiego di 1-carnitina per migliorare i paramenti biochimici e comportamentali dell'eta' senile
JP2518636B2 (ja) * 1987-02-13 1996-07-24 雪印乳業株式会社 重症感染症及び広範囲熱症治療経腸栄養剤
FR2635264B1 (fr) * 1988-08-12 1992-02-28 Bellon Labor Sa Roger Compositions pharmaceutiques et/ou dietetiques contenant de la l-carnitine et de la l-lysine
IT1245869B (it) * 1991-06-05 1994-10-25 Sigma Tau Ind Farmaceuti Impiego di propionil l-carnitina per il recupero del tono muscolare in soggetti immobilizzati
US5256697A (en) * 1992-04-16 1993-10-26 Abbott Laboratories Method of administering pyruvate and methods of synthesizing pyruvate precursors
IT1263004B (it) * 1992-10-08 1996-07-23 Sigma Tau Ind Farmaceuti Impiego della l-carnitina e acil l-carnitine nel trattamento a lungo termine di pazienti diabetici non insulino-dipendenti.
IT1291127B1 (it) * 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
PL213131B1 (pl) * 1999-10-11 2013-01-31 Sigma Tau Ind Farmaceuti Zastosowanie roztworu srodka osmotycznego i roztwór do dializy otrzewnowej
IT1316998B1 (it) * 2000-03-02 2003-05-26 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento degli effetticitotossici indotti dall'uso di agenti immunosoppressori.
US6630175B1 (en) 2000-06-29 2003-10-07 Johnson & Johnson Consumer Companies, Inc. Method of reducing eye irritation
US6432424B1 (en) * 2000-06-29 2002-08-13 Johnson & Johnson Consumer Companies, Inc. Cosmetic compositions containing creatine, carnitine, and/or pyruvic acid
US6649176B1 (en) 2000-06-29 2003-11-18 Johnson & Johnson Consumer Companies, Inc. Compositions containing mineral water
US6372791B1 (en) 2000-06-29 2002-04-16 Johnson & Johnson Consumer Companies, Inc. Method of promoting skin cell metabolism
GB0306394D0 (en) * 2003-03-20 2003-04-23 Univ Nottingham Carnitine retention
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
ITRM20040346A1 (it) * 2004-07-13 2004-10-13 Sigma Tau Ind Farmaceuti Uso della l-carnitina per il trattamento di patologie cardiovascolari.
US20060105972A1 (en) 2004-11-17 2006-05-18 Nagasawa Herbert T Method to enhance delivery of glutathione and ATP levels in cells
TW201201712A (en) * 2010-01-28 2012-01-16 Max International Llc Compositions comprising sugar-cysteine products

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE639532A (de) *
FR3707M (fr) * 1963-11-05 1965-11-22 Belge Produits Chimiques Sa Association de la carnitine a des émulsions lipidiques.
US3810994A (en) * 1972-06-01 1974-05-14 Ethyl Corp Method and composition for treating obesity
US3968241A (en) * 1972-11-06 1976-07-06 Defelice Stephen L Method of treating cardiac arrhythmias and of improving myocardial contractility and systolic rhythm with carnitive or a pharmaceutically acceptable salt thereof
US3830931A (en) * 1972-11-06 1974-08-20 Felice S De Carnitine and its use in the treatment of arrhythmia and impaired cardiac function
AU518617B2 (en) * 1977-04-29 1981-10-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Therapeutic application of acetyl-d, 1-carnitine
JPS5460236A (en) * 1977-10-21 1979-05-15 Mitsubishi Electric Corp Etching method
IT1156741B (it) * 1978-05-15 1987-02-04 Sigma Tau Ind Farmaceuti Applicazione terapeutica della carnitina e di alcuni derivati acilati della carnitina nell'emodialisi
IT1156769B (it) * 1978-05-25 1987-02-04 Sigma Tau Ind Farmaceuti Applicazione terapeutica della carnitina e di altri acil derivati della carnitina
IT1116037B (it) 1979-04-23 1986-02-10 Sigma Tau Ind Farmaceuti Esteri e ammidi di acil carnitine loro procedimenti di preparazione e loro uso terapeutico
DE2921852A1 (de) * 1979-05-29 1980-12-11 Fresenius Chem Pharm Ind Lipide senkendes mittel
DE3026368A1 (de) * 1980-07-11 1982-02-18 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Naehrloesung fuer die vollstaendige parenterale ernaehrung und fuer gesteigerte energieproduktion

Also Published As

Publication number Publication date
IL61190A (en) 1984-06-29
IL61190A0 (en) 1980-11-30
GB2059262A (en) 1981-04-23
GB2059262B (en) 1983-11-09
JPS643847B2 (de) 1989-01-23
BE885527A (fr) 1981-02-02
ATA495580A (de) 1985-03-15
DE3037479A1 (de) 1981-05-21
CA1154678A (en) 1983-10-04
DE3037479C2 (de) 1988-09-08
CH641675A5 (it) 1984-03-15
US4320145A (en) 1982-03-16
FR2468371A1 (fr) 1981-05-08
IT7950467A0 (it) 1979-10-05
IT1120033B (it) 1986-03-19
FR2468371B1 (de) 1984-05-04
AT395111B (de) 1992-09-25
JPS5661310A (en) 1981-05-26
NL8005450A (nl) 1981-04-07

Similar Documents

Publication Publication Date Title
LU82818A1 (fr) Compositions pharmaceutiques pour nutrition parenterale
EP1879656B1 (de) Pharmazeutische zusammensetzung mit einem antitumoralen mittel und einem insbesondere aus carveol, thymol und carvacrol ausgewählten wirkstoff
FR2654932A1 (fr) Composition anorexigene.
WO1998001118A1 (fr) Composition pharmaceutique pour administration par voie orale
FR2760972A1 (fr) Utilisation de l-citrulline en medecine orthomoleculaire pour la vasoprotection, le tonus relaxatif des muscles lisses et la protection cellulaires
CH683067A5 (fr) Composition pour augmenter l'activité renfermant de la tyrosine et un médicament sympathomimétique.
WO1994012193A1 (fr) Combinaison de cisplatine avec l'oxaliplatine
EP2451436A1 (de) Verfahren und pharmazeutische zusammensetzungen für transbukkale schleimhautbehandlung von postprandialer hyperglykämie bei typ-ii-diabetes
EP0655244B2 (de) Zusammensetzungen aus Aminosäure zur Behandlung von Infektionen
LU82013A1 (fr) Nouvelles poudres lyophilisees contenant un sel de l'acide thiazolidine-4-carboxylique et leur procede de preparation
FR3007985A1 (fr) Medicament pour la prevention et le traitement des facteurs de risques cardiometaboliques, en particulier maladies cardiovasculaires, pre-diabete, diabete de type ii et steatose hepatique
BE1023090B1 (fr) Composition
EP3624822B1 (de) Aktive zusammensetzung enthaltend eine mischung von poly-lysine verbindungen, und verwendung zur behandlung und vorbeugung der entzündung nach schlaganfall
WO2015000986A1 (fr) Composition intervenant dans la regulation du dysfonctionnement des cycles de l'energie, de l'inflammation et de l'insulinoresistance et son utilisation notamment dans les maladies cardiometaboliques
FR2922109A1 (fr) Composition pharmaceutique ou dietetique pour inhiber l'absorption intestinale du sucre.
CA3157656A1 (fr) Utilisation de nictotinamide mononucleotide (nmn) pour la prevention et/ou le traitement de la polyarthrite rhumatoide et compositions correspondantes
WO2002009740A1 (fr) Composition contenant une proteine complexant le fer et un precurseur du metabolisme du monoxyde d'azote et/ou un donneur chimique de monoxyde d'azote et utilisations
US20060105965A1 (en) Method for enhancing energy levels and reducing the effects of stress using nutraceutical formulations
US20150202181A1 (en) Method of and compounds for the reduction of alcoholic hangover
FR3007986A1 (fr) Medicament destine a lutter contre l'infertilite et la sous-fertilite en particulier dans le cadre d'une sous fertilite ou infertilite metabolique
FR2991181A1 (fr) Composition pharmaceutique ou dietetique pour inhiber l'absorption intestinale du sucre et utilisable pour soigner le syndrome metabolique
CA2792993A1 (fr) Composition particuliere pour son application comme medicament
FR2896127A1 (fr) Utilisation nouvelle d'une composition alimentaire a usage humain ou veterinaire pauvre en polyamines pour la realisation d'un aliment therapeutique
FR2643266A1 (fr) Solute d'apport d'acides amines pour alimentation parenterale
CH718339A2 (fr) Formulations pour perfusions intraveineuses comprenant un complexe d'inclusion d'un stilbène en synergie avec des microquantités de mélatonine.